| | |
Page
|
| |||
| | | | ii | | | |
| | | | iii | | | |
| | | | 1 | | | |
| | | | 3 | | | |
| | | | 5 | | | |
| | | | 31 | | | |
| | | | 34 | | | |
| | | | 34 | | | |
| | | | 35 | | | |
| | | | 36 | | | |
| | | | 37 | | | |
| | | | 44 | | | |
| | | | 56 | | | |
| | | | 64 | | | |
| | | | 70 | | | |
| | | | 75 | | | |
| | | | 77 | | | |
| | | | 78 | | | |
| | | | 88 | | | |
| | | | 89 | | | |
| | | | 93 | | | |
| | | | 93 | | | |
| | | | 93 | | | |
| | | | F-1 | | |
| | |
For the Three
Months Ended March 31, 2021 |
| |
For the Three
Months Ended March 31, 2020 |
| |
Restated
Year ended December 31, 2020 |
| |
For the period
from April 30, 2019 to December 31, 2019 |
| ||||||||||||
Net sales
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Selling and administrative expenses .
|
| | | | 14,394 | | | | | | 3,522 | | | | | | 28,787 | | | | | | 4,526 | | |
Research and development expenses .
|
| | | | 91,812 | | | | | | 8,468 | | | | | | 73,694 | | | | | | 5,865 | | |
Total operating expenses .
|
| | | $ | (106,206) | | | | | $ | (11,990) | | | | | $ | (102,481) | | | | | $ | (10,391) | | |
Loss from operations
|
| | | | | | | | | | | | | | | $ | (102,481) | | | | | $ | (10,391) | | |
Other (expense) income
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Other (expense) income.
|
| | | | (19,132) | | | | | | 126 | | | | | | (20,866) | | | | | | — | | |
Interest income (expense) .
|
| | | | 127 | | | | | | (1) | | | | | | (703) | | | | | | — | | |
Loss before income taxes.
|
| | | $ | (125,211) | | | | | $ | (11,865) | | | | | $ | (124,050) | | | | | $ | (10,391) | | |
Income tax expense.
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss.
|
| | | $ | (125,211) | | | | | $ | (11,865) | | | | | $ | (124,050) | | | | | $ | (10,391) | | |
Loss per share attributable to common shareholders. | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic & Diluted
|
| | | $ | (0.72) | | | | | $ | (0.16) | | | | | $ | (1.28) | | | | | $ | (0.15) | | |
Weighted-average number of common shares outstanding
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Basic & Diluted
|
| | | | 174,325 | | | | | | 71,911 | | | | | | 96,716 | | | | | | 68,279 | | |
| | |
March 31,
2021 |
| |
Restated
December 31, 2020 |
| |
December 31,
2019 |
| |||||||||
Total assets
|
| | | $ | 779,082 | | | | | $ | 767,219 | | | | | $ | 33,546 | | |
Total liabilities
|
| | | | 75,767 | | | | | | 136,481 | | | | | | 24,990 | | |
Total stockholders’ equity
|
| | | | 703,315 | | | | | | 630,738 | | | | | | 8,556 | | |
(in thousands)
|
| |
Three months
ended March 31, 2021 |
| |
Three months
ended March 31, 2020 |
| ||||||
Net sales
|
| | | $ | — | | | | | $ | — | | |
Operating expenses | | | | | | | | | | | | | |
Selling and administrative expenses
|
| | | | 14,394 | | | | | | 3,522 | | |
Research and development expenses .
|
| | | | 91,812 | | | | | | 8,468 | | |
Total operating expenses .
|
| | | | 106,206 | | | | | | 11,990 | | |
Loss from operations
|
| | | | (106,206) | | | | | | (11,990) | | |
Other (expense) income
|
| | | | | | | | | | | | |
Other (expense) income
|
| | | | (19,132) | | | | | | 126 | | |
Interest income (expense) .
|
| | | | 127 | | | | | | (1) | | |
Loss before income taxes
|
| | | | (125,211) | | | | | | (11,865) | | |
Income tax expense
|
| | | | — | | | | | | — | | |
Net loss .
|
| | | $ | (125,211) | | | | | $ | (11,865) | | |
(in thousands)
|
| |
Restated Year
ended December 31, 2020 |
| |
For the Period
April 30, 2019 to December 31, 2019 |
| ||||||
Net sales
|
| | | $ | — | | | | | $ | — | | |
Operating expenses | | | | | | | | | | | | | |
Selling and administrative expenses
|
| | | | 28,787 | | | | | | 4,526 | | |
Research and development expenses
|
| | | | 73,694 | | | | | | 5,865 | | |
Total operating expenses
|
| | | | 102,481 | | | | | | 10,391 | | |
Loss from operations
|
| | | | (102,481) | | | | | | (10,391) | | |
Other (expense) income
|
| | | | | | | | | | | | |
Other expense, net
|
| | | | (20,866) | | | | | | — | | |
Interest expense
|
| | | | (703) | | | | | | — | | |
Loss before income taxes
|
| | | | (124,050) | | | | | | (10,391) | | |
Income tax expense
|
| | | | — | | | | | | — | | |
Net loss
|
| | | $ | (124,050) | | | | | $ | (10,391) | | |
(in thousands)
|
| |
Three months
ended March 31, 2021 |
| |
Three months
ended March 31, 2020 |
| |
Restated Year
ended December 31, 2020 |
| |
For the Period
April 30, 2019 to December 31, 2019 |
| ||||||||||||
Net cash used by operating activities
|
| | | $ | (71,520) | | | | | $ | (7,855) | | | | | $ | (99,596) | | | | | $ | (5,202) | | |
Net cash used by investing activities
|
| | | $ | (54,264) | | | | | $ | — | | | | | $ | (50,249) | | | | | $ | (133) | | |
Net cash provided by financing activities
|
| | | $ | 83,066 | | | | | $ | 6,125 | | | | | $ | 777,447 | | | | | $ | 7,494 | | |
Name
|
| |
Age
|
| |
Position
|
|
Executive Officers | | | | | | | |
Angela Strand | | |
52
|
| | Executive Chair of the Board | |
Rebecca A. Roof | | |
65
|
| | Interim Chief Financial Officer | |
Jane Ritson-Parsons | | |
58
|
| | Chief Operating Officer | |
Rich Schmidt | | |
54
|
| | President | |
Shane Brown | | |
50
|
| | Chief Production Officer | |
Chuan D. (John) Vo | | |
48
|
| | Vice President of Propulsion | |
Darren Post | | |
61
|
| | Vice President of Engineering | |
Thomas V. Canepa | | |
61
|
| | General Counsel and Corporate Secretary | |
Non-Employee Directors | | | | | | | |
David T. Hamamoto(3) | | |
61
|
| | Director | |
Keith Feldman(1) | | |
45
|
| | Director | |
Jane Reiss(1) | | |
60
|
| | Director | |
Dale Spencer(2)(3) | | |
63
|
| | Director | |
Michael Gates(3) | | |
60
|
| | Director | |
Mick Kowitz(2) | | |
54
|
| | Director | |
Martin J. Rucidlo(1) | | |
64
|
| | Director | |
Name and Principal Position
|
| |
Year
|
| |
Salary
($) |
| |
Option
Awards ($)(l) |
| |
Total
($) |
| ||||||||||||
Stephen S. Burns
Former Chief Executive Officer |
| | | | 2020 | | | | | | 269,266 | | | | | | — | | | | | | 269,266 | | |
| | | 2019 | | | | | | 99,113 | | | | | | — | | | | | | 99,113 | | | ||
Phil Richard Schmidt
President |
| | | | 2020 | | | | | | 324,265 | | | | | | 88,040 | | | | | | 412,305 | | |
Thomas V. Canepa
General Counsel & Corporate Secretary |
| | | | 2020 | | | | | | 292,345 | | | | | | 88,040 | | | | | | 380,385 | | |
| | |
Option Awards
|
| |||||||||||||||||||||||||||
Name
|
| |
Grant
Date |
| |
Number of
Securities Underlying Unexercised Options Exercisable (#) |
| |
Number of
Securities Underlying Unexercised Options Unexercisable (#) |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |||||||||||||||
Stephen S. Burns
|
| | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Phil Richard Schmidt
|
| | | | 11/1/19(1) | | | | | | 470,254 | | | | | | 232,449 | | | | | $ | 1.79 | | | | | | 10/31/29 | | |
| | | | | 2/14/20(1) | | | | | | 54,528 | | | | | | 26,858 | | | | | $ | 1.79 | | | | | | 2/13/30 | | |
Thomas V. Canepa
|
| | | | 11/1/19(1) | | | | | | 470,254 | | | | | | 232,449 | | | | | $ | 1.79 | | | | | | 10/31/29 | | |
| | | | | 2/14/20(1) | | | | | | 54,528 | | | | | | 26,858 | | | | | $ | 1.79 | | | | | | 2/13/30 | | |
Name
|
| |
Stock
Awards ($)(1) |
| |
Total
($) |
| ||||||
Jane Reiss
|
| | | | 150,880(2) | | | | | | 150,880 | | |
Dale Spencer
|
| | | | 150,880(2) | | | | | | 150,880 | | |
Name and Address of Beneficial Owner
|
| |
Common Stock
Beneficially Owned Number of Shares of Class A Common Stock Beneficially Owned |
| |
Percent of Class A
Common Stock Outstanding |
| ||||||
Directors and Named Executive Officers | | | | | | | | | | | | | |
Keith Feldman(1)
|
| | | | 234,645 | | | | | | * | | |
Michael Gates
|
| | | | 10,101 | | | | | | * | | |
David THamamoto(2)
|
| | | | 4,229,135 | | | | | | 2.37% | | |
Mick Kowitz
|
| | | | 10,060 | | | | | | * | | |
Jane Reiss(3)
|
| | | | 83,822 | | | | | | * | | |
Martin JRucidlo
|
| | | | 12,535 | | | | | | * | | |
Dale Spencer(3)
|
| | | | 83,822 | | | | | | * | | |
Angela Strand
|
| | | | — | | | | | | * | | |
Stephen SBurns(4)
|
| | | | 46,351,745 | | | | | | 26.25% | | |
Thomas VCanepa(5)
|
| | | | 538,752 | | | | | | * | | |
Phil Richard Schmidt(6)
|
| | | | 334,148 | | | | | | * | | |
All Current Directors and Executive Officers, as a group
(16 individuals)(7) |
| | | | 5,676,660 | | | | | | 3.16% | | |
Five Percent Holders | | | | | | | | | | | | | |
Workhorse Group Inc.(8)
|
| | | | 16,478,402 | | | | | | 9.33% | | |
FMR LLC(9)
|
| | | | 10,433,286 | | | | | | 5.91% | | |
Name of Selling Stockholder
|
| |
Number of Shares of
Class A Common Stock Owned Prior to Offering |
| |
Maximum Number of
Shares of Class A Common Stock to be Offered Pursuant to this Prospectus |
| |
Number of Shares of
Class A Common Stock Owned After Offering |
| |||||||||||||||||||||
| | |
Number(1)
|
| |
Percent
|
| | | | | | | |
Number(2)
|
| |
Percent
|
| ||||||||||||
YA II PN, LTD.(3)
|
| | | | 371,287 | | | | | | * | | | | | | 35,144,690 | | | | | | — | | | | | | — | | |
Redemption Date
|
| |
Fair Market Value of Class A Common Stock
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
(period to expiration of Warrants)
|
| | | $ | 10.00 | | | | | $ | 11.00 | | | | | $ | 12.00 | | | | | $ | 13.00 | | | | | $ | 14.00 | | | | | $ | 15.00 | | | | | $ | 16.00 | | | | | $ | 17.00 | | | | | $ | 18.00 | | |
57 months
|
| | | | 0.257 | | | | | | 0.277 | | | | | | 0.294 | | | | | | 0.310 | | | | | | 0.324 | | | | | | 0.337 | | | | | | 0.348 | | | | | | 0.358 | | | | | | 0.365 | | |
54 months
|
| | | | 0.252 | | | | | | 0.272 | | | | | | 0.291 | | | | | | 0.307 | | | | | | 0.322 | | | | | | 0.335 | | | | | | 0.347 | | | | | | 0.357 | | | | | | 0.365 | | |
51 months
|
| | | | 0.246 | | | | | | 0.268 | | | | | | 0.287 | | | | | | 0.304 | | | | | | 0.320 | | | | | | 0.333 | | | | | | 0.346 | | | | | | 0.357 | | | | | | 0.365 | | |
48 months
|
| | | | 0.241 | | | | | | 0.263 | | | | | | 0.283 | | | | | | 0.301 | | | | | | 0.317 | | | | | | 0.332 | | | | | | 0.344 | | | | | | 0.356 | | | | | | 0.365 | | |
45 months
|
| | | | 0.235 | | | | | | 0.258 | | | | | | 0.279 | | | | | | 0.298 | | | | | | 0.315 | | | | | | 0.330 | | | | | | 0.343 | | | | | | 0.356 | | | | | | 0.365 | | |
42 months
|
| | | | 0.228 | | | | | | 0.252 | | | | | | 0.274 | | | | | | 0.294 | | | | | | 0.312 | | | | | | 0.328 | | | | | | 0.342 | | | | | | 0.355 | | | | | | 0.364 | | |
39 months
|
| | | | 0.221 | | | | | | 0.246 | | | | | | 0.269 | | | | | | 0.290 | | | | | | 0.309 | | | | | | 0.325 | | | | | | 0.340 | | | | | | 0.354 | | | | | | 0.364 | | |
36 months
|
| | | | 0.213 | | | | | | 0.239 | | | | | | 0.263 | | | | | | 0.285 | | | | | | 0.305 | | | | | | 0.323 | | | | | | 0.339 | | | | | | 0.353 | | | | | | 0.364 | | |
33 months
|
| | | | 0.205 | | | | | | 0.232 | | | | | | 0.257 | | | | | | 0.280 | | | | | | 0.301 | | | | | | 0.320 | | | | | | 0.337 | | | | | | 0.352 | | | | | | 0.364 | | |
30 months
|
| | | | 0.196 | | | | | | 0.224 | | | | | | 0.250 | | | | | | 0.274 | | | | | | 0.297 | | | | | | 0.316 | | | | | | 0.335 | | | | | | 0.351 | | | | | | 0.364 | | |
27 months
|
| | | | 0.185 | | | | | | 0.214 | | | | | | 0.242 | | | | | | 0.268 | | | | | | 0.291 | | | | | | 0.313 | | | | | | 0.332 | | | | | | 0.350 | | | | | | 0.364 | | |
24 months
|
| | | | 0.173 | | | | | | 0.204 | | | | | | 0.233 | | | | | | 0.260 | | | | | | 0.285 | | | | | | 0.308 | | | | | | 0.329 | | | | | | 0.348 | | | | | | 0.364 | | |
21 months
|
| | | | 0.161 | | | | | | 0.193 | | | | | | 0.223 | | | | | | 0.252 | | | | | | 0.279 | | | | | | 0.304 | | | | | | 0.326 | | | | | | 0.347 | | | | | | 0.364 | | |
18 months
|
| | | | 0.146 | | | | | | 0.179 | | | | | | 0.211 | | | | | | 0.242 | | | | | | 0.271 | | | | | | 0.298 | | | | | | 0.322 | | | | | | 0.345 | | | | | | 0.363 | | |
15 months
|
| | | | 0.130 | | | | | | 0.164 | | | | | | 0.197 | | | | | | 0.230 | | | | | | 0.262 | | | | | | 0.291 | | | | | | 0.317 | | | | | | 0.342 | | | | | | 0.363 | | |
12 months
|
| | | | 0.111 | | | | | | 0.146 | | | | | | 0.181 | | | | | | 0.216 | | | | | | 0.250 | | | | | | 0.282 | | | | | | 0.312 | | | | | | 0.339 | | | | | | 0.363 | | |
9 months
|
| | | | 0.090 | | | | | | 0.125 | | | | | | 0.162 | | | | | | 0.199 | | | | | | 0.237 | | | | | | 0.272 | | | | | | 0.305 | | | | | | 0.336 | | | | | | 0.362 | | |
6 months
|
| | | | 0.065 | | | | | | 0.099 | | | | | | 0.137 | | | | | | 0.178 | | | | | | 0.219 | | | | | | 0.259 | | | | | | 0.296 | | | | | | 0.331 | | | | | | 0.362 | | |
3 months
|
| | | | 0.034 | | | | | | 0.065 | | | | | | 0.104 | | | | | | 0.150 | | | | | | 0.197 | | | | | | 0.243 | | | | | | 0.286 | | | | | | 0.326 | | | | | | 0.361 | | |
0 months
|
| | | | — | | | | | | — | | | | | | 0.042 | | | | | | 0.115 | | | | | | 0.179 | | | | | | 0.233 | | | | | | 0.281 | | | | | | 0.323 | | | | | | 0.361 | | |
| For the Three Months Ended March 31, 2021 and 2020 | | | | | | | |
| Unaudited Condensed Consolidated Financial Statements | | | | | | | |
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
|
For the Year Ended December 31, 2020 and For the Period from April 30, 2019 through December 2019 (As Restated for the year ended December 31, 2020)
|
| | | | | | |
| Audited Consolidated Financial Statements | | | | | | | |
| | | | | F-16 | | | |
| | | | | F-18 | | | |
| | | | | F-19 | | | |
| | | | | F-20 | | | |
| | | | | F-21 | | | |
| | | | | F-22 | | |
| | |
March 31,
2021 |
| |
Restated
December 31, 2020 |
| ||||||
ASSETS:
|
| | | | | | | | | | | | |
Current Assets | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 587,043 | | | | | $ | 629,761 | | |
Accounts receivable
|
| | | | 5 | | | | | | 21 | | |
Prepaid expenses and other current assets
|
| | | | 25,989 | | | | | | 24,663 | | |
Total current assets
|
| | | $ | 613,037 | | | | | $ | 654,445 | | |
Property, plant and equipment
|
| | | | 154,934 | | | | | | 101,663 | | |
Intangible assets
|
| | | | 11,111 | | | | | | 11,111 | | |
Total Assets
|
| | | $ | 779,082 | | | | | $ | 767,219 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY:
|
| | | | | | | | | | | | |
Current Liabilities | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 58,961 | | | | | $ | 32,536 | | |
Accrued and other current liabilities
|
| | | | 8,041 | | | | | | 1,538 | | |
Total current liabilities
|
| | | $ | 67,002 | | | | | $ | 34,074 | | |
Note payable
|
| | | | 1,015 | | | | | | 1,015 | | |
Warrant liability
|
| | | | 7,750 | | | | | | 101,392 | | |
Total liabilities
|
| | | $ | 75,767 | | | | | $ | 136,481 | | |
Stockholders’ equity | | | | | | | | | | | | | |
Class A common stock, $0.0001 par value, 300,000,000 shares authorized;
176,579,376 and 168,007,960 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively |
| | | $ | 18 | | | | | $ | 17 | | |
Additional paid in capital
|
| | | | 962,949 | | | | | | 765,162 | | |
Accumulated deficit
|
| | | | (259,652) | | | | | | (134,441) | | |
Total stockholders’ equity
|
| | | $ | 703,315 | | | | | $ | 630,738 | | |
Total liabilities and stockholder’s equity
|
| | | $ | 779,082 | | | | | $ | 767,219 | | |
| | |
Three months
ended March 31, 2021 |
| |
Three months
ended March 31, 2020 |
| ||||||
Net sales
|
| | | $ | — | | | | | $ | — | | |
Operating expenses | | | | | | | | | | | | | |
Selling and administrative expenses
|
| | | | 14,394 | | | | | | 3,522 | | |
Research and development expenses
|
| | | | 91,812 | | | | | | 8,468 | | |
Total operating expenses
|
| | | $ | 106,206 | | | | | $ | 11,990 | | |
Loss from operations
|
| | | $ | (106,206) | | | | | $ | (11,990) | | |
Other (expense) income | | | | | | | | | | | | | |
Other (expense) income .
|
| | | | (19,132) | | | | | | 126 | | |
Interest income (expense)
|
| | | | 127 | | | | | | (1) | | |
Loss before income taxes
|
| | | $ | (125,211) | | | | | $ | (11,865) | | |
Income tax expense
|
| | | | — | | | | | | — | | |
Net loss
|
| | | $ | (125,211) | | | | | $ | (11,865) | | |
Loss per share attributable to common shareholders | | | | | | | | | | | | | |
Basic & Diluted
|
| | | $ | (0.72) | | | | | $ | (0.16) | | |
Weighted-average number of common shares outstanding
|
| | | | | | | | | | | | |
Basic & Diluted
|
| | | | 174,325 | | | | | | 71,911 | | |
| | |
Common Stock
|
| |
Additional
Paid-In Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity |
| ||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||
Balance at December 31, 2019
|
| | | | 68,279 | | | | | | 7 | | | | | | 18,940 | | | | | | (10,391) | | | | | | 8,556 | | |
Issuance of common stock
|
| | | | 4,701 | | | | | | 1 | | | | | | 6,403 | | | | | | — | | | | | | 6,404 | | |
Stock compensation
|
| | | | — | | | | | | — | | | | | | 130 | | | | | | — | | | | | | 130 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (11,865) | | | | | | (11,865) | | |
Balance at March 31, 2020
|
| | | | 72,980 | | | | | | 8 | | | | | | 25,473 | | | | | | (22,256) | | | | | | 3,225 | | |
Balance at December 31, 2020 – Restated
|
| | | | 168,008 | | | | | $ | 17 | | | | | $ | 765,162 | | | | | $ | (134,441) | | | | | $ | 630,738 | | |
Issuance of common stock
|
| | | | 587 | | | | | | — | | | | | | 1,050 | | | | | | — | | | | | | 1,050 | | |
Common stock issued for exercise of
warrants . |
| | | | 7,984 | | | | | | 1 | | | | | | 194,797 | | | | | | — | | | | | | 194,798 | | |
Stock compensation
|
| | | | | | | | | | — | | | | | | 1,940 | | | | | | — | | | | | | 1,940 | | |
Net loss
|
| | | | | | | | | | — | | | | | | — | | | | | | (125,211) | | | | | | (125,211) | | |
Balance at March 31, 2021
|
| | | | 176,579 | | | | | $ | 18 | | | | | $ | 962,949 | | | | | $ | (259,652) | | | | | $ | 703,315 | | |
| | |
Three months
ended March 31, 2021 |
| |
Three months
ended March 31, 2020 |
| ||||||
Cash flows from operating activities | | | | | | | | | | | | | |
Net loss .
|
| | | $ | (125,211) | | | | | $ | (11,865) | | |
Adjustments to reconcile net loss to cash used by operating activities:
|
| | | | | | | | | | | | |
Stock-based compensation
|
| | | | 1,940 | | | | | | 130 | | |
Non-cash charge related to change in fair value of warrants
|
| | | | 19,138 | | | | | | — | | |
Changes in assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivables
|
| | | | 16 | | | | | | — | | |
Prepaid expenses .
|
| | | | (1,325) | | | | | | (55) | | |
Accounts payable .
|
| | | | 27,418 | | | | | | 3,944 | | |
Accrued expenses and due to related party
|
| | | | 6,504 | | | | | | (9) | | |
Cash used by operating activities
|
| | | $ | (71,520) | | | | | $ | (7,855) | | |
Cash flows from investing activities | | | | | | | | | | | | | |
Purchases of capital assets
|
| | | $ | (54,264) | | | | | $ | — | | |
Cash used by investing activities
|
| | | $ | (54,264) | | | | | $ | — | | |
Cash flows from financing activities | | | | | | | | | | | | | |
Cash proceeds from exercise of warrants
|
| | | $ | 82,016 | | | | | $ | — | | |
Issuance of common stock
|
| | | | 1,050 | | | | | | 6,125 | | |
Cash provided by financing activities
|
| | | $ | 83,066 | | | | | $ | 6,125 | | |
Decrease in cash and cash equivalents
|
| | | $ | (42,718) | | | | | $ | (1,730) | | |
Cash and cash equivalents, beginning balance .
|
| | | | 629,761 | | | | | | 2,159 | | |
Cash and cash equivalents, ending balance
|
| | | $ | 587,043 | | | | | $ | 429 | | |
Non cash items | | | | | | | | | | | | | |
Capital assets acquired with payables
|
| | | $ | 4,599 | | | | | $ | — | | |
| | |
Three monthsended
March 31, 2021 |
| |||
Public Warrants
|
| | | $ | (27,180) | | |
Private Warrants
|
| | | | 8,042 | | |
Net loss on changes in fair value .
|
| | | $ | (19,138) | | |
| | |
Total
|
| |
Quoted prices in
active markets (Level 1) |
| |
Prices with
observable inputs (Level 2) |
| |
Prices with
unobservable inputs (Level 3) |
| ||||||||||||
March 31, 2021 | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 587,043 | | | | | $ | 587,043 | | | | | $ | — | | | | | $ | — | | |
Public Warrants
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Private Warrants
|
| | | | 7,750 | | | | | | — | | | | | | — | | | | | | 7,750 | | |
| | |
Total
|
| |
Quoted prices in
active markets (Level 1) |
| |
Prices with
observable inputs (Level 2) |
| |
Prices with
unobservable inputs (Level 3) |
| ||||||||||||
December 31, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 629,761 | | | | | $ | 629,761 | | | | | $ | — | | | | | $ | — | | |
Public Warrants .
|
| | | | 57,515 | | | | | | 57,515 | | | | | | — | | | | | | — | | |
Private Warrants
|
| | | | 43,877 | | | | | | — | | | | | | — | | | | | | 43,877 | | |
| | |
Balance at
December 31, 2020 |
| |
Additions
|
| |
Settlements
|
| |
Loss/(Gain) on fair
value adjustments included in earnings |
| |
Balance at
March 31, 2021 |
| |||||||||||||||
Private Warrants .
|
| | | $ | 43,877 | | | | | | — | | | | | | (28,085) | | | | | | (8,042) | | | | | $ | 7,750 | | |
| | |
March 31, 2021
|
| |
December 31, 2020
|
| ||||||
Property, Plant & Equipment | | | | | | | | | | | | | |
Land
|
| | | $ | 326 | | | | | $ | 326 | | |
Buildings
|
| | | | 6,223 | | | | | | 6,223 | | |
Machinery and equipment
|
| | | | 38,443 | | | | | | 38,443 | | |
Vehicles
|
| | | | 142 | | | | | | 142 | | |
Construction in progress
|
| | | | 109,800 | | | | | | 56,529 | | |
| | | | $ | 154,934 | | | | | $ | 101,663 | | |
Less: Accumulated depreciation
|
| | | | — | | | | | | — | | |
Total .
|
| | | $ | 154,934 | | | | | $ | 101,663 | | |
| | |
Three months
ended March 31, 2021 |
| |
Three months
ended March 31, 2020 |
| ||||||
Basic and diluted weighted average shares outstanding
|
| | | | 174,325 | | | | | | 71,911 | | |
| | |
Restated
December 31, 2020 |
| |
December 31, 2019
|
| ||||||
ASSETS:
|
| | | | | | | | | | | | |
Current Assets | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 629,761 | | | | | $ | 2,159 | | |
Accounts receivable
|
| | | | 21 | | | | | | — | | |
Prepaid expenses and other current assets
|
| | | | 24,663 | | | | | | — | | |
Total current assets .
|
| | | $ | 654,445 | | | | | $ | 2,159 | | |
Property, plant and equipment .
|
| | | | 101,663 | | | | | | 20,276 | | |
Intangible assets
|
| | | | 11,111 | | | | | | 11,111 | | |
Total Assets .
|
| | | $ | 767,219 | | | | | $ | 33,546 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY:
|
| | | | | | | | | | | | |
Current Liabilities | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,536 | | | | | $ | 1,802 | | |
Accrued and other current liabilities
|
| | | | 1,538 | | | | | | 415 | | |
Due to related party
|
| | | | — | | | | | | 2,631 | | |
Related party notes payable .
|
| | | | — | | | | | | 20,142 | | |
Total current liabilities
|
| | | $ | 34,074 | | | | | $ | 24,990 | | |
Note payable .
|
| | | | 1,015 | | | | | | — | | |
Warrant Liability
|
| | | | 101,392 | | | | | | — | | |
Total liabilities .
|
| | | $ | 136,481 | | | | | $ | 24,990 | | |
Stockholders’ equity | | | | | | | | | | | | | |
Common stock, $0.0001 par value, 300,000,000 shares authorized; 168,007,960 and 68,279,182 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively
|
| | | $ | 17 | | | | | $ | 7 | | |
Additional paid in capital
|
| | | | 765,162 | | | | | | 18,940 | | |
Accumulated deficit
|
| | | | (134,441) | | | | | | (10,391) | | |
Total stockholders’ equity .
|
| | | $ | 630,738 | | | | | $ | 8,556 | | |
Total liabilities and stockholder’s equity .
|
| | | $ | 767,219 | | | | | $ | 33,546 | | |
| | |
Restated
Yearended December 31, 2020 |
| |
For the period
from April 30, 2019 to December 31, 2019 |
| ||||||
Net sales
|
| | | $ | — | | | | | $ | — | | |
Operating expenses | | | | | | | | | | | | | |
Selling and administrative expenses
|
| | | | 28,787 | | | | | | 4,526 | | |
Research and development expenses
|
| | | | 73,694 | | | | | | 5,865 | | |
Total operating expenses
|
| | | $ | 102,481 | | | | | $ | 10,391 | | |
Loss from operations
|
| | | $ | (102,481) | | | | | $ | (10,391) | | |
Other (expense) income
|
| | | | | | | | | | | | |
Other expense, net .
|
| | | | (20,866) | | | | | | — | | |
Interest expense
|
| | | | (703) | | | | | | — | | |
Loss before income taxes
|
| | | $ | (124,050) | | | | | $ | (10,391) | | |
Income tax expense
|
| | | | — | | | | | | — | | |
Net loss .
|
| | | $ | (124,050) | | | | | $ | (10,391) | | |
Loss per share attributable to common shareholders
Basic & Diluted . |
| | | $ | (1.28) | | | | | $ | (0.15) | | |
Weighted – average number of common shares outstanding
Basic & Diluted . |
| | | | 96,716 | | | | | | 68,279 | | |
| | |
Common Stock
|
| |
Restated
Additional Paid-In Capital |
| |
Restated
Accumulated Deficit |
| |
Restated
Total Stockholders’ Equity |
| ||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||
Inception at April 30, 2019
|
| | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of common stock
|
| | | | 68,279 | | | | | | 7 | | | | | | 18,598 | | | | | | — | | | | | | 18,605 | | |
Stock compensation
|
| | | | | | | | | | — | | | | | | 342 | | | | | | — | | | | | | 342 | | |
Net loss
|
| | | | | | | | | | — | | | | | | — | | | | | | (10,391) | | | | | | (10,391) | | |
Balance at December 31, 2019
|
| | | | 68,279 | | | | | $ | 7 | | | | | $ | 18,940 | | | | | $ | (10,391) | | | | | $ | 8,556 | | |
Issuance of common stock
|
| | | | 8,652 | | | | | | 2 | | | | | | 6,437 | | | | | | — | | | | | | 6,439 | | |
Common stock issued for conversion of notes payable
|
| | | | 4,032 | | | | | | 0 | | | | | | 38,725 | | | | | | — | | | | | | 38,725 | | |
Common stock issued for exercise of
warrants |
| | | | 2,669 | | | | | | — | | | | | | 53,724 | | | | | | — | | | | | | 53,724 | | |
Common stock issued in recapitalization, net of redemptions and transaction costs
|
| | | | 84,376 | | | | | | 8 | | | | | | 644,581 | | | | | | — | | | | | | 644,589 | | |
Stock compensation
|
| | | | | | | | | | — | | | | | | 2,755 | | | | | | — | | | | | | 2,755 | | |
Net loss
|
| | | | | | | | | | — | | | | | | — | | | | | | (124,050) | | | | | | (124,050) | | |
Balance at December 31, 2020
|
| | | | 168,008 | | | | | $ | 17 | | | | | $ | 765,162 | | | | | $ | (134,441) | | | | | $ | 630,738 | | |
| | |
Restated
Year ended December 31, 2020 |
| |
For the period from
April 30, 2019 to December 31, 2019 |
| ||||||
Cash flows from operating activities | | | | | | | | | | | | | |
Net loss
|
| | | $ | (124,050) | | | | | $ | (10,391) | | |
Adjustments to reconcile net loss to cash used by operating activities:
|
| | | | | | | | | | | | |
Stock-based compensation
|
| | | | 2,755 | | | | | | 342 | | |
Gain on disposal of fixed assets
|
| | | | (2,346) | | | | | | — | | |
Non-cash change in fair value related to warrants
|
| | | | 23,493 | | | | | | — | | |
Changes in assets and liabilities: | | | | | | | | | | | | | |
Accounts receivables
|
| | | | (21) | | | | | | — | | |
Prepaid expenses
|
| | | | (24,663) | | | | | | — | | |
Accounts payable .
|
| | | | 25,767 | | | | | | 1,801 | | |
Accrued expenses and due to related party
|
| | | | (531) | | | | | | 3,046 | | |
Cash used by operating activities
|
| | | $ | (99,596) | | | | | $ | (5,202) | | |
Cash flows from investing activities
|
| | | $ | | | | | $ | | | ||
Purchases of capital assets .
|
| | | | (52,645) | | | | | | (133) | | |
Proceeds from the sale of capital assets
|
| | | | 2,396 | | | | | | — | | |
Cash used by investing activities
|
| | | $ | (50,249) | | | | | $ | (133) | | |
Cash flows from financing activities
|
| | | $ | | | | | $ | | | ||
Proceeds from notes payable
|
| | | | 38,796 | | | | | | — | | |
Cash received in recapitalization, net of transaction costs
|
| | | | 701,520 | | | | | | — | | |
Cash proceeds from exercise of warrants
|
| | | | 30,692 | | | | | | — | | |
Issuance of common stock
|
| | | | 6,439 | | | | | | 7,494 | | |
Cash provided by financing activities
|
| | | $ | 777,447 | | | | | $ | 7,494 | | |
Increase in cash and cash equivalents
|
| | | $ | 627,602 | | | | | $ | 2,159 | | |
Cash and cash equivalents, beginning balance .
|
| | | | 2,159 | | | | | | — | | |
Cash and cash equivalents, ending balance
|
| | | $ | 629,761 | | | | | $ | 2,159 | | |
Non cash items | | | | | | | | | | | | | |
Conversion of notes payable to equity .
|
| | | $ | 38,725 | | | | | $ | — | | |
Capital assets acquired with payables
|
| | | $ | 5,592 | | | | | $ | 20,142 | | |
Capital assets exchanged for equity
|
| | | $ | 23,200 | | | | | $ | — | | |
Common stock issued in exchange for intangible assets .
|
| | | $ | — | | | | | $ | 11,111 | | |
(in thousands except for per share amounts)
|
| |
Originally Reported
|
| |
Adjustments
|
| |
Restated
|
| |||||||||
Consolidated Balance Sheet | | | | | |||||||||||||||
Warrant Liability
|
| | | $ | — | | | | | $ | 101,392 | | | | | $ | 101,392 | | |
Total liabilities
|
| | | | 35,089 | | | | | | 101,392 | | | | | | 136,481 | | |
Additional paid in capital
|
| | | | 843,061 | | | | | | (77,899) | | | | | | 765,162 | | |
Accumulated deficit
|
| | | | (110,948) | | | | | | (23,493) | | | | | | (134,441) | | |
Total stockholders’ equity
|
| | | | 732,130 | | | | | | (101,392) | | | | | | 630,738 | | |
Consolidated Statement of Operations | | | | | | | | | | | | | | | | | | | |
Other expense, net
|
| | | | 2,627 | | | | | | (23,493) | | | | | | (20,866) | | |
Loss before income taxes
|
| | | | (100,557) | | | | | | (23,493) | | | | | | (124,050) | | |
Net loss
|
| | | | (100,557) | | | | | | (23,493) | | | | | | (124,050) | | |
Loss per share attributable to common shareholders | | | | | | | | | | | | | | | | | | | |
Basic & Diluted
|
| | | | (1.04) | | | | | | (0.24) | | | | | | (1.28) | | |
Consolidated Statement of Stockholders’ Equity | | | | | | | | | | | | | | | | | | | |
Common stock issued for exercise of warrants
|
| | | | 30,692 | | | | | | 23,032 | | | | | | 53,724 | | |
Common stock issued in recapitalization, net of redemptions and transaction costs
|
| | | | 745,512 | | | | | | (100,931) | | | | | | 644,581 | | |
Net loss
|
| | | | (100,557) | | | | | | (23,493) | | | | | | (124,050) | | |
Additional Paid-In Capital – Balance at December 31, 2020
|
| | | | 843,061 | | | | | | (77,899) | | | | | | 765,162 | | |
Accumulated Deficit – Balance at December 31, 2020
|
| | | | (110,948) | | | | | | (23,493) | | | | | | (134,441) | | |
Total Stockholders’ Equity
|
| | | | 732,130 | | | | | | (101,392) | | | | | | 630,738 | | |
Statement of Cashflows | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | | (100,557) | | | | | | (23,493) | | | | | | (124,050) | | |
Non-cash change in fair value related to warrants
|
| | | | — | | | | | | 23,493 | | | | | | 23,493 | | |
Prepaid expenses
|
| | | | (17,367) | | | | | | (7,296) | | | | | | (24,663) | | |
Accounts payable
|
| | | | 31,360 | | | | | | (5,593) | | | | | | 25,767 | | |
Accrued expenses and due to related party
|
| | | | 21,856 | | | | | | (22,387) | | | | | | (531) | | |
Cash used by operating activities
|
| | | | (64,320) | | | | | | (35,276) | | | | | | (99,596) | | |
Purchases of capital assets
|
| | | | (58,237) | | | | | | 5,592 | | | | | | (52,645) | | |
Cash used by investing activities
|
| | | | (55,841) | | | | | | 5,592 | | | | | | (50,249) | | |
Cash received in recapitalization, net of transaction costs
|
| | | | 671,836 | | | | | | 29,684 | | | | | | 701,520 | | |
Cash provided by financing activities
|
| | | | 747,763 | | | | | | 29,684 | | | | | | 777,447 | | |
Capital assets acquired with payables
|
| | | | — | | | | | | 5,592 | | | | | | 5,592 | | |
| | |
Year ended
December 31, 2020 |
| |||
Public Warrants
|
| | | $ | (17,920) | | |
Private Warrants
|
| | | | (5,573) | | |
Net loss on changes in fair value
|
| | | $ | (23,493) | | |
| | |
Total
|
| |
Quoted prices
in active markets (Level 1) |
| |
Prices with
observable inputs (Level 2) |
| |
Prices with
unobservable inputs (Level 3) |
| ||||||||||||
December 31, 2019 | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 2,159 | | | | | $ | 2,159 | | | | | $ | — | | | | | $ | — | | |
| | |
Total
|
| |
Quoted prices
in active markets (Level 1) |
| |
Prices with
observable inputs (Level 2) |
| |
Prices with
unobservable inputs (Level 3) |
| ||||||||||||
December 31, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 629,761 | | | | | $ | 629,761 | | | | | $ | — | | | | | $ | — | | |
Public Warrants
|
| | | | 57,515 | | | | | | 57,515 | | | | | | — | | | | | | — | | |
Private Warrants
|
| | | | 43,877 | | | | | | — | | | | | | — | | | | | | 43,877 | | |
| | |
Balance at
December 31, 2019 |
| |
Additions
|
| |
Settlements
|
| |
Loss / (Gain) on
fair value adjustments included in earnings |
| |
Balance at
December 31, 2020 |
| |||||||||||||||
Private Warrants
|
| | | $ | — | | | | | | 38,304 | | | | | | — | | | | | | 5,573 | | | | | $ | 43,877 | | |
(in thousands)
|
| |
2020
|
| |
2019
|
| ||||||
Property, Plant & Equipment | | | | | | | | | | | | | |
Land
|
| | | $ | 326 | | | | | $ | — | | |
Buildings
|
| | | | 6,223 | | | | | | — | | |
Machinery and equipment
|
| | | | 38,443 | | | | | | — | | |
Vehicles
|
| | | | 142 | | | | | | — | | |
Construction in progress
|
| | | | 56,529 | | | | | | 20,276 | | |
| | | | $ | 101,663 | | | | | $ | 20,276 | | |
Less: Accumulated depreciation
|
| | | | — | | | | | | — | | |
Total
|
| | | $ | 101,663 | | | | | $ | 20,276 | | |
| | |
December 31,
2020 |
| |
December 31,
2019 |
| ||||||
Risk-free interest rate
|
| | | | 1.59% | | | | | | 1.73 – 1.93% | | |
Expected term (life) of options (in years)
|
| | | | 10.0 | | | | | | 10.0 | | |
Expected dividends
|
| | | | —% | | | | | | —% | | |
Expected volatility
|
| | | | 50% | | | | | | 50% | | |
(in thousands except for per option values and years)
|
| |
Number
of Options |
| |
Weighted Average
Grant Date Fair Value per Option |
| |
Weighted Average
Exercise Price |
| |
Weighted Average
Remaining Contractual Term (Years) |
| ||||||||||||
Outstanding, April 30, 2019
|
| | | | — | | | | | $ | — | | | | | $ | — | | | | | | — | | |
Granted
|
| | | | 4,436 | | | | | | 1.09 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
Forfeited
|
| | | | (84) | | | | | | 1.09 | | | | | | | | | | | | | | |
Expired
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
Outstanding, December 31, 2019
|
| | | | 4,352 | | | | | $ | 1.09 | | | | | $ | 1.79 | | | | | | 8.9 | | |
Granted
|
| | | | 1,021 | | | | | | 1.08 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
Forfeited
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
Expired
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
Outstanding, December 31, 2020
|
| | | | 5,373 | | | | | $ | 1.09 | | | | | $ | 1.79 | | | | | | 9.0 | | |
(in thousands)
|
| |
For the
year ended December 31, 2020 |
| |
For the
period from April 30, 2019 to December 31, 2019 |
| ||||||
Basic and diluted weighted average shares outstanding
|
| | | | 96,716 | | | | | | 68,279 | | |
(in thousands except for rate)
|
| |
2020
|
| |
Rate
|
| |
2019
|
| |
Rate
|
| ||||||||||||
Federal tax benefit as statutory rates – restated
|
| | | $ | (26,050) | | | | | | (21.0)% | | | | | $ | (2,182) | | | | | | (21.0)% | | |
Stock based compensation
|
| | | | 192 | | | | | | 0.2 | | | | | | 21 | | | | | | 0.2 | | |
Other permanent differences
|
| | | | 32 | | | | | | — | | | | | | 1 | | | | | | — | | |
Change in valuation allowance – restated
|
| | | | 25,826 | | | | | | 20.8 | | | | | | 2,160 | | | | | | 20.8 | | |
Total tax benefit
|
| | | $ | — | | | | | | —% | | | | | $ | — | | | | | | —% | | |
| | |
2020
|
| |
2019
|
| ||||||
Deferred tax assets: | | | | | | | | | | | | | |
Non-qualified stock options
|
| | | $ | 436 | | | | | $ | 50 | | |
Net operating losses
|
| | | | 27,550 | | | | | | 2,110 | | |
Total deferred tax assets
|
| | | | 27,986 | | | | | | 2,160 | | |
Valuation allowance
|
| | | | (27,986) | | | | | | (2,160) | | |
Total deferred tax assets, net of valuation allowance
|
| | | $ | — | | | | | $ | — | | |
(in thousands)
|
| |
Operating Leases
|
| |||
2021
|
| | | | 892 | | |
2022
|
| | | | 919 | | |
2023
|
| | | | 942 | | |
2024
|
| | | | 956 | | |
2025
|
| | | | 974 | | |
Thereafter
|
| | | | 1,003 | | |
Total minimum lease payments
|
| | | $ | 5,686 | | |